Keratin bioceramic compositions

Patent metadata

Field	Value
Publication number	US-11173233-B2
Application number	US-201414547839-A
Country	US
Kind code	B2
Filing date	Nov 19, 2014
Priority date	Oct 21, 2005
Publication date	Nov 16, 2021
Grant date	Nov 16, 2021

Abstract

A malleable bone graft composition is described. The composition comprises: (a) keratose; (b) particulate filler; (c) antibiotic; and (d) water. The invention may be provided in sterile form in an container, and optionally lyophilized. Methods of treating a fracture with such compositions are also described.

First claim

That which is claimed is:

1. A method of treating a fracture in a subject in need thereof, comprising contacting to said fracture in a treatment-effective amount: a malleable bone graft composition, comprising:
(a) from 5 to 30 percent by weight keratose, wherein the keratose is present in the composition as a keratose hydrogel;
(b) from 1 to 30 percent by weight particulate filler;
(c) from 0.001 to 5 percent by weight antibiotic; and
(d) water to attain 100 percent by weight,

wherein a ratio of the particulate filler to the keratose is from 0.1:1 to 1:1.

2. The method of claim 1 , wherein said keratose comprises a mixture of alpha keratose and gamma keratose.

3. The method of claim 2 , wherein said keratose comprises from 10 to 90 percent by weight of the alpha keratose and from 90 to 10 percent by weight of the gamma keratose.

4. The method of claim 1 , wherein said keratose hydrogel comprises crosslinked keratose.

5. The method of claim 4 , wherein said crosslinked keratose is produced by the process of combining said keratose with transglutaminase in the presence of a calcium initiator.

6. The method of claim 1 , wherein the composition further comprises from 0.001 to 5 percent by weight bone morphogenic protein.

7. The method of claim 1 , wherein said particulate filler is osteoconductive.

8. The method of claim 1 , wherein said particulate filler is selected from the group consisting of tetracalcium phosphate, tricalcium phosphate, calcium alkali phosphate ceramic, bioglass, calcium carbonate, calcium hydroxide, calcium oxide, calcium fluoride, calcium sulfate, magnesium hydroxide, hydroxyapatite, calcium phosphorus apatite, magnesium oxide, magnesium carbonate, magnesium fluoride, collagen, and mixtures thereof.

9. The method of claim 1 , wherein said particulate filler comprises hydroxyapatite, tricalcium phosphate, or a mixture thereof.

10. The method of claim 1 , wherein said antibiotic is selected from the group consisting of cefazolin, vancomycin, gentamycin, erythromycin, bacitracin, neomycin, penicillin, polymycin B, tetracycline, biomycin, chloromycetin, streptomycin, ampicillin, azactam, tobramycin, clindamycin, gentamicin and combinations thereof.

11. The method of claim 1 , wherein said composition is sterile.

12. The method of claim 1 , further comprising a step of reconstituting a lyophilized or freeze-dried composition comprising the keratose, particulate filler, and antibiotic with water or saline solution to produce said malleable bone graft composition prior to said contacting step.

13. The method of claim 1 , wherein said composition comprises from 5 to 20 percent by weight of said keratose.

14. The method of claim 1 , wherein said composition comprises from 7 to 20 percent by weight of said keratose.

15. The method of claim 1 , wherein said composition comprises from 5 to 10 percent by weight of said keratose.

16. The method of claim 1 , wherein said composition comprises from 7 to 10 percent by weight of said keratose.

17. The method of claim 1 , wherein said composition is a putty comprising a matrix of the keratose hydrogel.

Assignees

• Univ Wake Forest Health Sciences

Inventors

• Van Dyke Mark E

Classifications

• A61L27/425

  of phosphorus containing material, e.g. apatite · CPC title

• A61L27/54 Primary

  Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title

• A61L27/58

  Materials at least partially resorbable by the body · CPC title

• A61L2300/406

  Antibiotics · CPC title

• A61L2430/02

  for reconstruction of bones; weight-bearing implants · CPC title